Progress Statement from Dr Brian Kushner at MSKCC December 2009
“We are well on our way to meeting our goal for patients enrolled in our new clinical study. Over the last 5 months, since the trial opened, several patients have received the trivalent vaccine for the treatment of neuroblastoma. There have been no severe side effects. At this rate, we anticipate continued accrual and completion of enrollment within the next 1-2 years. That is a tremendous pace for an undertaking of this type, and we are thankful to Soupy for Loopy for your support of our efforts. Studies like this one bring us one step closer to being able to provide effective treatments for neuroblastoma and putting an end to the suffering caused by this disease.”
Great news!!!
SOUPY FOR LOOPY is a registered servicemark of Soupy for Loopy Foundation, Inc.
